BioMed Realty Trust, Inc. has completed a 295,000 s/f lease at 675 West Kendall to Alnylam Pharmaceuticals, providing Alnylam with class A laboratory and office space in Kendall Sq. The lease was brokered by Transwestern | RBJ, which represented both sides in this transaction.
Alnylam Pharmaceuticals is leading the translation of RNAi as a new class of innovative medicines, with a core focus on RNAi therapeutics toward genetically defined targets for the treatment of serious, life-threatening diseases with limited treatment options for patients and their caregivers. This growing life science company will occupy all the rentable space available on the six floors of 675 West Kendall when the lease with the current tenant, Vertex Pharmaceuticals, ends in May 2018.
Since the beginning of the year, BioMed Realty has signed new leases in Kendall Sq. and East Cambridge aggregating almost 500,000 s/f, reflecting the demand and vitality of the largest life science urban center in the world.
"BioMed Realty has built our business on helping life science companies be successful by providing the laboratory and office platform for companies like Alnylam to conduct breakthrough science that help patients throughout the world," said Bill Kane, senior vice president for BioMed Realty. "We will welcome Alnylam to their new home, and provide them our unique real estate expertise to ensure they have the best facility to create life-changing treatments for patients."
As a tenant at 675 West Kendall, Alnylam employees will have the benefit of engaging in an amenity-rich, privately owned and operated 10-acre mixed use site that offers top-quality restaurants, kayak and canoe rentals, ice skating, outdoor concerts, and a farmers market.
BioMed Realty, with its trusted expertise and valuable relationships, delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising 18 million s/f.